Affiliation:
1. Department of Radiology, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea School of Medicine, Seoul 21431, Republic of Korea
2. Department of Radiology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea School of Medicine, Seoul 06591, Republic of Korea
3. Department of General Surgery, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea School of Medicine, Seoul 21431, Republic of Korea
Abstract
This study aimed to determine whether apparent diffusion coefficient (ADC) and morphological features on diffusion-weighted MRI (DW-MRI) can discriminate metastatic axillary lymph nodes (ALNs) from benign in patients with breast cancer. Two radiologists measured ADC, long and short diameters, long-to-short diameter ratio, and cortical thickness and assessed eccentric cortical thickening, loss of fatty hilum, irregular margin, asymmetry in shape or number, and rim sign of ALNs on DW-MRI and categorized them into benign or suspicious ALNs. Pathologic reports were used as a reference standard. Statistical analysis was performed using the Mann–Whitney U test and chi-square test. Overall sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy of DW-MRI were calculated. The ADC of metastatic ALNs was 0.905 × 10−3 mm2/s, and that of benign ALNs was 0.991 × 10−3 mm2/s (p = 0.243). All morphologic features showed significant difference between the two groups. The sensitivity, specificity, PPV, NPV, and diagnostic accuracy of the final categorization on DW-MRI were 77.1%, 93.3%, 79.4%, 92.5%, and 86.2%, respectively. Our results suggest that morphologic evaluation of ALNs on DWI can discriminate metastatic ALNs from benign. The ADC value of metastatic ALNs was lower than that of benign nodes, but the difference was not statistically significant.
Reference41 articles.
1. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases;Carter;Cancer,1989
2. (2019, October 29). Surveillance, Epidemiology, and End RESULTS Program (SEER). Table 4.13: Cancer of the Female Breast (Invasive)—5 Year Relative and Period Survival by Race, Diagnosis Year, Ange and Stage at Diagnosis. In: SEER Cancer Statistics Review (CSR) 1975–2016. SEER Website, Available online: https://seer.cancer.gov/csr/1975_2016/browse_csr.php?sectionSEL=4&pageSEL=sect_04_table.13.
3. What is the future of axillary surgery for breast cancer?;Ahmed;Ecancermedicalscience,2013
4. Apparent diffusion coefficient magnetic resonance imaging (adc-mri) in the axillary breast cancer lymph node metastasis detection: A narrative review;Bruno;Gland Surg.,2020
5. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy;Schijven;Eur. J. Surg. Oncol.,2003